|
Hugh Lewis is the Vice President of Manufacturing at Cytonome. Hugh was formerly the VP of Operations for Systemix, a cell therapy company. In this position, Mr. Lewis was involved in the development of a clinical-grade flow cytometer. Mr. Lewis has built and operated cGMP manufacturing lines and facilities for production of cell-based biologic products, clinical grade monoclonal antibodies, and several additional regulated medical devices. He has over 20 years experience in product manufacturing for medical products and medical devices, including positions at Baxter Travenol and Sanofi Diagnostics Pasteur. | 